Birth control pills could increase risk of blood clots

Learn about signs of blood clots, and what type of birth control may be right for you.

close-up of woman holding birth control pills

Updated on June 25, 2024.

If you’re among the 14 percent of women aged 15 to 49 in the United States who currently take birth control pills, you may be at risk of developing a blood clot. But there are many types of birth control pills and very different risk levels, depending on your health situation. Here’s what to know about birth control pills and blood clots.

The role of blood clots

Blood clots are your body’s way of healing itself. When you get cut or injured, your body starts to form blood clots. These are little clumps of blood that feel sort of like gel. They stop the bleeding by sealing up the wound so that healing can begin.

But in rare instances, blood clots can form inside the veins, plugging up the flow of blood. This is called venous thromboembolism (VTE). It can lead to serious health issues. VTEs include:

  • Deep vein thrombosis (DVT): This is a blood clot that occurs in a vein, usually in the legs.
  • Pulmonary embolism: This is when a blood clot dislodges and travels to the lungs, where it can get stuck in an artery. This can cause a potentially fatal blockage.

These kinds of clots need immediate medical attention. Some forms of hormone therapy, including birth control pills, can slightly raise the risk of VTE.

Estrogen

A common ingredient in contraceptive pills and in hormone replacement therapy, estrogen can be very useful. But estrogen can sometimes affect proteins in the blood and cause it to be more likely to clot. This can raise the risk of blood clots forming in the legs or in the blood vessels that move blood from the lungs to the heart.

Estrogen is usually used in combination with progesterone in birth control pills. Until the 1990s, estrogen was thought to be the cause of all blood clots related to contraceptive use. But starting in 1995, researchers began to find evidence that newer types of progesterone were also contributing to this risk.

Progesterone

Your body naturally makes progesterone. It helps build up the lining of the uterus and prepare it for a potentially fertilized egg during the menstrual cycle. It’s also an ingredient in combination birth control pills, or pills that contain both estrogen and progesterone.

Progestins are human-made forms of the hormone progesterone. Progestin-only contraceptives do not seem to increase the risk of blood clots. However, newer forms of the hormone progesterone may raise the risk of blood clots when combined with estrogen. The current evidence for this is somewhat uncertain. Some studies show an increased risk while others do not, according to a 2022 review published in the journal Research and Practice in Thrombosis and Haemostasis.

Still, the American College of Obstetricians and Gynecologists (ACOG) states that combined hormonal methods that include a progestin known as drospirenone can slightly raise the risk of DVT.

Symptoms of blood clots

Sometimes, blood clots do not have symptoms. It depends on where in the body the clot forms, and how much it blocks the flow of blood. Symptoms of clots that form in the legs, chest or arms may include:

  • Sharp pain in the chest or calf
  • Shortness of breath
  • Coughing up blood
  • Uneven or faster than usual heartbeat
  • Weakness or numbness in the arms or legs
  • Swelling, pain, or skin color changes in the leg

If you experience any of these symptoms, call 911 or go an emergency room right away.

What to know about risk of clots

Though birth control pills do carry some added risk for blood clots, it’s quite small. The overall risk of VTE related to oral birth control pills is not much higher than the risk for people not on any form of birth control. And it’s actually lower than for those who are pregnant.

Hormonal birth control causes VTE in up to 10 people in every 10,000 each year. People who aren’t on birth control experience clots at a rate of about 1-5 people per 10,000 each year. And the rate of clots among pregnant people is about 10 to 20 per 10,000 people each year. And for some, the medical benefits of taking hormone therapies far outweigh potential harms.

Recent research has suggested that transgender women who are on hormonal treatment may have an increased risk of VTE compared to cisgender women or men. More studies are needed, but if you have a history of VTE and are transgender, be sure to discuss alternative hormone therapy approaches with your healthcare provider (HCP). Transdermal estrogen may be a safer method of hormonal therapy. It is absorbed through the skin and comes in sprays, gels, and patches.  

The best birth control method for you

If you take birth control pills or are interested in starting or switching to a new method of birth control, discuss the risks and benefits with your HCP. Be open about your medical history and habits so they can assess your individual risk for VTE.

Smoking, having a family history of blood clots, being overweight, being 35 or older, or having a history of stroke, migraine with aura, ischemic heart disease, or other cardiovascular diseases can all make you more susceptible to clotting. Speak with your HCP to ensure you’re prescribed the safest form of birth control for your situation.

Article sources open article sources

Gomes MP, Deitcher SR. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med. 2004 Oct 11;164(18):1965-76.
Penn Medicine. Evaluating Blood Clots with Birth Control, Pregnancy, and HRT. Page accessed June 25, 2024.
Centers for Disease Control and Prevention. National Center for Health Statistics: Contraceptive Use. Page last reviewed December 7, 2022.
Mayo Clinic. Blood Clots. July 19, 2023.
National Heart, Lung, and Blood Institute. What is Venous Thromboembolism? Page last updated September 19, 2022.
Abou-Ismail MY, Citla Sridhar D, Nayak L. Estrogen and thrombosis: A bench to bedside review. Thromb Res. 2020 Aug;192:40-51.
Cleveland Clinic. Pulmonary Veins. Page last reviewed June 2, 2022.
Cleveland Clinic. Progesterone. Page last reviewed December 29, 2022.
LaVasseur C, Neukam S, Kartika T, et al. Hormonal therapies and venous thrombosis: Considerations for prevention and management. Res Pract Thromb Haemost. 2022 Aug 23;6(6):e12763.
The American College of Obstetricians and Gynecologists. Combined Hormonal Birth Control: Pill, Patch, and Ring—Frequently Asked Questions. Page accessed October 25, 2023.
Mayo Clinic. Deep vein thrombosis (DVT). June 11, 2022.
Cleveland Clinic. Blood Clots. Page last reviewed April 3, 2023.
Centers for Disease Control and Prevention. Venous Thromboembolism (Blood Clots). Page last reviewed June 28, 2023.
Cleveland Clinic. What to know about birth control and blood clots. April 26, 2022.
Centers for Disease Control and Prevention. What is Venous Thromboembolism? Page last reviewed June 28, 2023.

More On

Considering an IUD? Avoid these myths

article

Considering an IUD? Avoid these myths
Don’t let fears about pain, infection, and infertility prevent you from getting an IUD. Get the facts.
Are you at risk for HPV? Find out now

article

Are you at risk for HPV? Find out now
The most common sexually transmitted infection can lead to several forms of cancer. Here’s how to protect yourself.
News: Study says birth control may not be linked to depression

article

News: Study says birth control may not be linked to depression
Researchers didn't find a connection between mood changes and hormonal injections, implants and pills.
Questions to ask when starting a new form of birth control

article

Questions to ask when starting a new form of birth control
Why staying honest and realistic with yourself and your healthcare provider are key to using any form of birth control.
How insurance providers deny access to no-cost birth control

article

How insurance providers deny access to no-cost birth control
If your health insurance provider isn’t providing birth control at no cost, they may be violating a federal law.